Nina Zila, Ossia M Eichhoff, Irene Steiner, Thomas Mohr, Andrea Bileck, Phil F Cheng, Alexander Leitner, Ludovic Gillet, Tatjana Sajic, Sandra Goetze, Betty Friedrich, Patricia Bortel, Johanna Strobl, René Reitermaier, Sabrina A Hogan, Julia M Martínez-Gómez, Ramon Staeger, Felix Tuchmann, Sophie Peters, Georg Stary, Mario Kuttke, Adelheid Elbe-Buerger, Christoph Hoeller, Rainer Kunstfeld, Wolfgang Weninger, Bernd Wollscheid, Reinhard Dummer, Lars E French, Christopher Gerner, Ruedi Aebersold, Mitchell P Levesque, Verena Paulitschke
PURPOSE: Despite high clinical need, there are no biomarkers that accurately predict the response of patients with metastatic melanoma to anti-PD-1 therapy. EXPERIMENTAL DESIGN: In this multicenter study, we applied protein depletion and enrichment methods prior to various proteomic techniques to analyze a serum discovery cohort (n=56) and three independent serum validation cohorts (n=80; n=12; n=17). Further validation analyses by literature and survival analysis followed...
October 20, 2023: Clinical Cancer Research